• 1. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

Introduction to 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid (CAS No. 2680854-24-2)

2-(5-acetamido-1H-pyrazol-1-yl)acetic acid, identified by its Chemical Abstracts Service (CAS) number 2680854-24-2, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic derivative features a pyrazole core functionalized with an acetamide group and an acetic acid moiety, making it a versatile scaffold for drug discovery and molecular probe development. The unique structural attributes of this compound have positioned it as a valuable intermediate in the synthesis of biologically active molecules, particularly those targeting inflammatory and immunomodulatory pathways.

The pyrazole scaffold is renowned for its broad spectrum of biological activities, owing to its ability to interact with various enzyme systems and receptor targets. In particular, pyrazole derivatives have been extensively studied for their potential in treating neurological disorders, infectious diseases, and metabolic conditions. The presence of the acetamido group in 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid enhances its solubility and metabolic stability, facilitating its use in drug formulations. Furthermore, the terminal acetic acid moiety provides a site for further chemical modification, enabling the development of prodrugs or conjugates with enhanced pharmacokinetic properties.

Recent advancements in medicinal chemistry have highlighted the importance of 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid as a key intermediate in the synthesis of novel therapeutic agents. For instance, researchers have leveraged this compound to develop inhibitors of cyclooxygenase (COX) enzymes, which play a critical role in prostaglandin synthesis and are implicated in pain, inflammation, and cancer progression. The pyrazole core allows for selective binding to target enzymes while minimizing off-target effects, making this compound an attractive candidate for structure-based drug design.

In addition to its applications in anti-inflammatory therapy, 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid has been explored in the context of immunomodulation. Studies have demonstrated its ability to modulate immune cell function by interacting with receptors such as Toll-like receptors (TLRs) and interleukin receptors. These interactions can lead to the development of novel immunotherapies for autoimmune diseases and chronic infections. The compound's ability to cross-link with biologically relevant targets has also made it a valuable tool in the development of diagnostic imaging agents.

The synthesis of 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid typically involves multi-step organic transformations starting from commercially available precursors. Key steps include nucleophilic substitution reactions at the pyrazole ring to introduce the acetamide group, followed by carboxylation at the terminal position to form the acetic acid moiety. Advances in catalytic methods have enabled more efficient and scalable synthetic routes, reducing costs and improving yields. These improvements are crucial for industrial applications where cost-effectiveness and reproducibility are paramount.

The pharmacological profile of 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid has been extensively characterized through both computational modeling and experimental studies. Molecular docking simulations have revealed that this compound binds tightly to target proteins with high affinity, suggesting potential therapeutic efficacy. In vitro assays have further confirmed its ability to modulate biological pathways relevant to inflammation and immunity. These findings have spurred interest in clinical trials where 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid derivatives are being tested for their potential as lead compounds in drug development.

The growing body of research on 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid underscores its significance as a pharmacophore in medicinal chemistry. Its unique structural features make it an ideal candidate for further derivatization, allowing chemists to explore new chemical space and discover novel therapeutic agents. As computational methods continue to advance, virtual screening approaches are being employed to identify new analogs with improved pharmacokinetic properties and reduced toxicity.

In conclusion, 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid (CAS No. 2680854-24-2) represents a promising scaffold for drug discovery with applications spanning multiple therapeutic areas. Its structural versatility, coupled with its biological activity, makes it a valuable asset in pharmaceutical research. As our understanding of molecular interactions continues to evolve, compounds like 2-(5-acetamido-1H-pyrazol-1-yl)acetic acid will undoubtedly play a pivotal role in shaping the future of medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)